Oddo BHF Asset Management Sas Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Oddo BHF Asset Management Sas purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 76,529 shares of the healthcare conglomerate's stock, valued at approximately $44,742,000. UnitedHealth Group makes up about 2.2% of Oddo BHF Asset Management Sas' investment portfolio, making the stock its 4th biggest holding.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. State Street Corp grew its position in UnitedHealth Group by 1.3% in the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate's stock worth $26,626,387,000 after acquiring an additional 563,554 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of UnitedHealth Group by 1.6% during the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate's stock valued at $11,440,133,000 after acquiring an additional 318,039 shares during the last quarter. Franklin Resources Inc. boosted its position in UnitedHealth Group by 2.5% during the third quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate's stock worth $4,884,019,000 after purchasing an additional 193,800 shares during the period. Bank of New York Mellon Corp grew its stake in UnitedHealth Group by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate's stock valued at $4,094,247,000 after buying an additional 35,533 shares during the last quarter. Finally, International Assets Investment Management LLC boosted its holdings in UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock valued at $3,096,896,000 after acquiring an additional 5,290,025 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 1.0 %

NYSE:UNH traded up $4.92 on Friday, reaching $520.68. The company's stock had a trading volume of 8,201,924 shares, compared to its average volume of 3,987,167. The business's 50-day moving average price is $583.29 and its two-hundred day moving average price is $559.30. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The firm has a market cap of $479.17 billion, a PE ratio of 33.88, a PEG ratio of 1.57 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts' consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same period last year, the business posted $6.56 earnings per share. The firm's quarterly revenue was up 9.2% on a year-over-year basis. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.61%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group's dividend payout ratio (DPR) is currently 54.72%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on UNH. Truist Financial reiterated a "buy" rating and issued a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Bank of America reduced their target price on UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating on the stock in a report on Wednesday, October 16th. Stephens lifted their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a research report on Thursday, December 5th. HSBC cut UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Thursday, October 17th. Finally, Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating for the company in a research report on Wednesday, October 16th. Three research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of "Moderate Buy" and an average target price of $626.84.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.